PL3240529T3 - Stabilne kompozycje farmaceutyczne zawierające mykafunginę - Google Patents
Stabilne kompozycje farmaceutyczne zawierające mykafunginęInfo
- Publication number
- PL3240529T3 PL3240529T3 PL15817912T PL15817912T PL3240529T3 PL 3240529 T3 PL3240529 T3 PL 3240529T3 PL 15817912 T PL15817912 T PL 15817912T PL 15817912 T PL15817912 T PL 15817912T PL 3240529 T3 PL3240529 T3 PL 3240529T3
- Authority
- PL
- Poland
- Prior art keywords
- micafungin
- pharmaceutical compositions
- stable pharmaceutical
- stable
- compositions
- Prior art date
Links
- 108010021062 Micafungin Proteins 0.000 title 1
- PIEUQSKUWLMALL-YABMTYFHSA-N micafungin Chemical compound C1=CC(OCCCCC)=CC=C1C1=CC(C=2C=CC(=CC=2)C(=O)N[C@@H]2C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C2)[C@H](O)CC(N)=O)[C@H](O)[C@@H](O)C=2C=C(OS(O)(=O)=O)C(O)=CC=2)[C@@H](C)O)=O)=NO1 PIEUQSKUWLMALL-YABMTYFHSA-N 0.000 title 1
- 229960002159 micafungin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14200697 | 2014-12-31 | ||
| EP15817912.7A EP3240529B1 (en) | 2014-12-31 | 2015-12-30 | Stable pharmaceutical compositions comprising micafungin |
| PCT/EP2015/081384 WO2016107890A1 (en) | 2014-12-31 | 2015-12-30 | Stable pharmaceutical compositions comprising micafungin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3240529T3 true PL3240529T3 (pl) | 2022-05-02 |
Family
ID=52134071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15817912T PL3240529T3 (pl) | 2014-12-31 | 2015-12-30 | Stabilne kompozycje farmaceutyczne zawierające mykafunginę |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3240529B1 (pl) |
| DK (1) | DK3240529T3 (pl) |
| ES (1) | ES2777942T3 (pl) |
| PL (1) | PL3240529T3 (pl) |
| WO (1) | WO2016107890A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3554474T3 (fi) * | 2016-12-16 | 2024-02-21 | Baxter Int | Mikafungiinikoostumuksia |
| US20220040092A1 (en) * | 2020-06-27 | 2022-02-10 | RK Pharma Solutions LLC | Ready to use injectable formulations of Micafungin Sodium |
| CN119523951A (zh) * | 2024-12-03 | 2025-02-28 | 上海欣峰制药有限公司 | 一种吡仑帕奈药物组合物及其制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
| JP2006069929A (ja) | 2004-08-31 | 2006-03-16 | Konica Minolta Medical & Graphic Inc | 真菌症治療製剤およびその製造方法 |
| CN102614491B (zh) * | 2011-01-31 | 2014-04-16 | 上海天伟生物制药有限公司 | 一种含有棘白菌素类抗真菌剂米卡芬净的药用组合物及其制备方法和用途 |
-
2015
- 2015-12-30 PL PL15817912T patent/PL3240529T3/pl unknown
- 2015-12-30 WO PCT/EP2015/081384 patent/WO2016107890A1/en not_active Ceased
- 2015-12-30 ES ES15817912T patent/ES2777942T3/es active Active
- 2015-12-30 DK DK15817912.7T patent/DK3240529T3/da active
- 2015-12-30 EP EP15817912.7A patent/EP3240529B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016107890A1 (en) | 2016-07-07 |
| ES2777942T3 (es) | 2022-04-22 |
| DK3240529T3 (da) | 2022-02-28 |
| EP3240529A1 (en) | 2017-11-08 |
| ES2777942T1 (es) | 2020-08-06 |
| EP3240529B1 (en) | 2022-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201605300B (en) | Pharmaceutical compositions comprising azd9291 | |
| GB201618482D0 (en) | Pharmaceutical compositions | |
| IL246978A0 (en) | New paracetamol formulations | |
| GB201419257D0 (en) | Pharmaceutical compositions | |
| HUE061809T2 (hu) | Készítmények csípõbél-éhbél szakaszba történõ hatóanyag beadáshoz | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| IL249553A0 (en) | Pharmaceutical preparations | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| ZA201702086B (en) | Long acting pharmaceutical compositions | |
| PT3122330T (pt) | Composições farmacêuticas compreendendo levocetirizina | |
| ZA201508726B (en) | Pharmaceutical composition | |
| ZA201502073B (en) | Pharmaceutical composition | |
| IL250817A0 (en) | pharmaceutical preparations | |
| PT3200772T (pt) | Composições farmacêuticas compreendendo alpelisib | |
| IL255510A (en) | Pharmaceutical compositions | |
| PL3240529T3 (pl) | Stabilne kompozycje farmaceutyczne zawierające mykafunginę | |
| PL3089740T3 (pl) | Kompozycja farmaceutyczna | |
| SG10201504332VA (en) | Pharmaceutical Composition | |
| GB201417589D0 (en) | Pharmaceutical Formulations | |
| PT3319596T (pt) | Composições farmacêuticas | |
| SG2014014872A (en) | Pharmaceutical compositions | |
| GB201408432D0 (en) | Pharmaceutical compositions | |
| GB201506598D0 (en) | Pharmaceutical compositions |